1. Home
  2. TLSI vs TG Comparison

TLSI vs TG Comparison

Compare TLSI & TG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • TLSI
  • TG
  • Stock Information
  • Founded
  • TLSI 2010
  • TG 1988
  • Country
  • TLSI United States
  • TG United States
  • Employees
  • TLSI N/A
  • TG N/A
  • Industry
  • TLSI Medical Specialities
  • TG Metal Fabrications
  • Sector
  • TLSI Health Care
  • TG Industrials
  • Exchange
  • TLSI Nasdaq
  • TG Nasdaq
  • Market Cap
  • TLSI 204.0M
  • TG 301.0M
  • IPO Year
  • TLSI N/A
  • TG 1989
  • Fundamental
  • Price
  • TLSI $5.43
  • TG $8.82
  • Analyst Decision
  • TLSI Strong Buy
  • TG
  • Analyst Count
  • TLSI 5
  • TG 0
  • Target Price
  • TLSI $10.90
  • TG N/A
  • AVG Volume (30 Days)
  • TLSI 146.8K
  • TG 71.1K
  • Earning Date
  • TLSI 08-13-2025
  • TG 08-06-2025
  • Dividend Yield
  • TLSI N/A
  • TG N/A
  • EPS Growth
  • TLSI N/A
  • TG N/A
  • EPS
  • TLSI N/A
  • TG N/A
  • Revenue
  • TLSI $32,141,000.00
  • TG $617,839,000.00
  • Revenue This Year
  • TLSI $55.52
  • TG N/A
  • Revenue Next Year
  • TLSI $54.76
  • TG N/A
  • P/E Ratio
  • TLSI N/A
  • TG N/A
  • Revenue Growth
  • TLSI 46.20
  • TG 17.42
  • 52 Week Low
  • TLSI $3.50
  • TG $4.58
  • 52 Week High
  • TLSI $6.04
  • TG $9.22
  • Technical
  • Relative Strength Index (RSI)
  • TLSI 50.01
  • TG 56.31
  • Support Level
  • TLSI $5.18
  • TG $8.45
  • Resistance Level
  • TLSI $5.65
  • TG $8.92
  • Average True Range (ATR)
  • TLSI 0.35
  • TG 0.21
  • MACD
  • TLSI -0.02
  • TG -0.02
  • Stochastic Oscillator
  • TLSI 49.23
  • TG 57.34

About TLSI TriSalus Life Sciences Inc.

TriSalus Life Sciences Inc is engaged in the research, development, and sales of drug delivery technology and immune-oncology therapeutics to improve outcomes in difficult-to-treat liver and pancreatic cancer. It is developing and marketing two product linesPressure Enabled Drug Delivery (PEDD) infusion systems, in use today, and an investigational agent, nelitolimod (SD-101), which shows potential to enhance immune system response in the treatment of hepatocellular cancer, pancreatic cancer and other liver solid tumors. TriNav is the newest therapy delivery device with SmartValve technology for the proprietary PEDD approach.

About TG Tredegar Corporation

Tredegar Corp, through its subsidiaries, engages in the manufacture of polyethylene plastic films, polyester films, and aluminum extrusions. Polyethylene plastic films produce plastic films, elastics, and laminate materials that are used in personal care products, surface protection films, and specialty and optical lighting applications. The company operates through segments including PE films, flexible packaging films, and aluminum extrusions. Aluminum extrusions generate the majority of revenue and provide high-quality, soft-alloy, medium-strength aluminum utilized in the building and construction, automotive, consumer durables, machinery and equipment, electrical, and distribution markets. Revenue is generated from the United States, Asia, and Brazil.

Share on Social Networks: